BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2580719)

  • 1. Interaction of tachykinins with an adrenergic receptor in the rat urinary bladder.
    Mathison R; Solomos D
    Eur J Pharmacol; 1985 Mar; 109(3):327-33. PubMed ID: 2580719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists.
    Mizrahi J; Dion S; D'Orléans-Juste P; Escher E; Drapeau G; Regoli D
    Eur J Pharmacol; 1985 Nov; 118(1-2):25-36. PubMed ID: 2417867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and autoradiographic localization of multiple tachykinin binding sites in gastrointestinal tract and bladder.
    Burcher E; Buck SH; Lovenberg W; O'Donohue TL
    J Pharmacol Exp Ther; 1986 Mar; 236(3):819-31. PubMed ID: 2419545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tachykinin antagonists: substitutions in positions 5 and 6 with amino acids from the primary sequence of substance P homologues.
    Mathison R; Escher E; Huggel H; Mizrahi J; Regoli D
    Eur J Pharmacol; 1985 Aug; 114(2):147-55. PubMed ID: 2412854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cardiovascular and bronchoconstrictor effects of substance P, substance K and other tachykinins.
    Hua X; Lundberg JM; Theodorsson-Norheim E; Brodin E
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Dec; 328(2):196-201. PubMed ID: 6084817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a new tachykinin antagonist.
    Mathison R; Stofer P; Barja F; Immer H
    Experientia; 1984 Jan; 40(1):86-8. PubMed ID: 6198202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the effects of three substance P antagonists on tachykinin-stimulated [3H]-acetylcholine release in the guinea-pig ileum.
    Featherstone RL; Fosbraey P; Morton IK
    Br J Pharmacol; 1986 Jan; 87(1):73-7. PubMed ID: 2420402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of substance P and other tachykinins on arterial pressure in guinea-pigs.
    Hancock JC; Hoover DB
    J Auton Pharmacol; 1985 Mar; 5(1):25-30. PubMed ID: 2580843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of receptors for two Xenopus gastrointestinal tachykinin peptides in their species of origin.
    Johansson A; Liu L; Holmgren S; Burcher E
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jul; 370(1):35-45. PubMed ID: 15235762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro actions of mammalian tachykinins.
    Holzer-Petsche U; Schimek E; Amann R; Lembeck F
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):130-5. PubMed ID: 2413373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parallel bioassay of physalaemin and kassinin, a tachykinin dodecapeptide from the skin of the African frog Kassina senegalensis.
    Erspamer GF; Erspamer V; Piccinelli D
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Feb; 311(1):61-5. PubMed ID: 6929037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contractile effects of substance P and other tachykinins on the mouse isolated distal colon.
    Fontaine J; Lebrun P
    Br J Pharmacol; 1989 Mar; 96(3):583-90. PubMed ID: 2470454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of two distinct tachykinin receptors in rat brain cortex.
    Cascieri MA; Chicchi GG; Liang T
    J Biol Chem; 1985 Feb; 260(3):1501-7. PubMed ID: 2578461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptors for substance P. II. Classification by agonist fragments and homologues.
    Regoli D; Mizrahi J; D'Orléans-Juste P; Escher E
    Eur J Pharmacol; 1984 Jan; 97(3-4):171-7. PubMed ID: 6200336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of tachykinin receptors examined by intracellular recording from chick sympathetic ganglia.
    Ramirez OA; Chiappinelli VA
    Brain Res; 1987 Jun; 414(2):228-38. PubMed ID: 2441802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the tachykinin antagonist, [D-Pro4, D-Trp7,9,10] substance P-(4-11), on tachykinin- and histamine-induced inositol phosphate generation in intestinal smooth muscle.
    Bailey SJ; Lippe IT; Holzer P
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):296-300. PubMed ID: 2438561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An examination of the pharmacology of two substance P antagonists and the evidence for tachykinin receptor subtypes.
    Bailey SJ; Featherstone RL; Jordan CC; Morton IK
    Br J Pharmacol; 1986 Jan; 87(1):79-85. PubMed ID: 2420403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further evidence for multiple tachykinin receptors.
    Growcott JW; Jamieson A; Tarpey AV; Topham LD
    Eur J Pharmacol; 1982 Dec; 86(1):59-64. PubMed ID: 6186499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural effects of intrathecally injected tachykinins in rats with peripheral nerve transection.
    Kuwahara H; Sakurada T; Sakurada S; Yonezawa A; Ando R; Kisara K; Osakada F; Munekata E
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):656-60. PubMed ID: 2451137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tachykinin NK1 receptor subtypes in the rat urinary bladder.
    Meini S; Patacchini R; Maggi CA
    Br J Pharmacol; 1994 Mar; 111(3):739-46. PubMed ID: 7517327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.